Single-cell transcriptome analysis revealed heterogeneity in glycolysis and identified IGF2 as a therapeutic target for ovarian cancer subtypes. Ji J, Bi F, Zhang X, Zhang Z, et al. BMC Cancer 2024;24:926.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ji J, Bi F, Zhang X, Zhang Z, et al. Single-cell transcriptome analysis revealed heterogeneity in glycolysis and identified IGF2 as a therapeutic target for ovarian cancer subtypes. BMC Cancer 2024;24:926.
PMID: 39085784